Zeke Capital Advisors LLC purchased a new stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 8,082 shares of the medical instruments supplier’s stock, valued at approximately $532,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. NuWave Investment Management LLC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $121,000. Focused Wealth Management Inc boosted its holdings in shares of DENTSPLY SIRONA by 79.2% in the 4th quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock valued at $171,000 after purchasing an additional 1,149 shares during the last quarter. First Interstate Bank acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $164,000. Stock Yards Bank & Trust Co. acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $203,000. Finally, Capital One National Association acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $204,000. Institutional investors own 96.80% of the company’s stock.
A number of equities analysts have recently commented on the stock. Barclays assumed coverage on shares of DENTSPLY SIRONA in a research note on Thursday, March 8th. They issued an “equal weight” rating and a $62.00 target price on the stock. JPMorgan Chase & Co. cut their target price on shares of DENTSPLY SIRONA from $75.00 to $70.00 and set an “overweight” rating on the stock in a research note on Monday, March 5th. Barrington Research reissued an “outperform” rating and issued a $70.00 target price (down previously from $73.00) on shares of DENTSPLY SIRONA in a research note on Monday, March 5th. HC Wainwright set a $63.00 target price on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a research note on Monday, March 5th. Finally, Credit Suisse Group cut their target price on shares of DENTSPLY SIRONA from $73.00 to $69.00 and set an “outperform” rating on the stock in a research note on Friday, March 2nd. Three analysts have rated the stock with a sell rating, four have given a hold rating and nine have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $67.43.
DENTSPLY SIRONA stock traded down $0.15 during trading on Monday, reaching $56.18. 166,094 shares of the company traded hands, compared to its average volume of 2,340,453. DENTSPLY SIRONA Inc has a 12-month low of $52.53 and a 12-month high of $68.98. The stock has a market cap of $12,808.04, a P/E ratio of 21.18, a price-to-earnings-growth ratio of 2.46 and a beta of 1.21. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.10 and a quick ratio of 1.45.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.01. DENTSPLY SIRONA had a negative net margin of 39.39% and a positive return on equity of 8.35%. The firm had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the firm posted $0.67 EPS. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. sell-side analysts predict that DENTSPLY SIRONA Inc will post 2.75 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Wednesday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -5.09%.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.